Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

• Status: Terminated
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a study to assess the response of lopinavir/ritonavir plus maraviroc (with no nucleoside medications) in HIV patients failing their initial antiviral therapy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rodwick, Barry M., M.D.
• Collaborator: Abbott
• Treatments: Lopinavir; Maraviroc; Ritonavir

Criteria

Inclusion Criteria:

• HIV viral load > 1,000 on current antiviral medications

• No resistance to study medications

• Over 18 years of age

Exclusion Criteria:

• Hepatitis B co-infection

• Pregnancy

• Previous therapy with either of the study medications

• Ongoing substance abuse

• Significant history of other physical disease